View Author

Kusuma, A.

(Ari Kusuma)


seizure duration esmolol seizure electroconvulsive therapy duration patient effect therapy study placebo electroconvulsive response session trial treatment pressure labetalol heart rate variable stimulus agent increase mm hg table method electrode placement dosage efficacy cuff method administration heart nicardipine control kovac publication weight psychiatry broek seizure threshold landiolol drug therapy outcome infusion randomized howie haemodynamic response comparison minute difference risk factors placement blood value tachycardia convulsion beta-adrenergic diastolic blood pressure pardo mp anaesthesia ect sessions measurement reduction anesth hypertensive response urapidil attenuated haemodynamic mcsweeney td disease anesthesia analg placebo-controlled infusion trials baseline hemodynamic systolic blood pressure diastolic attenuate block university hospital rotterdam-dijkzigt




3 Most Recent Publications

B and T cell imbalances in CSF of patients with Hu-antibody associated PNS (Article)
Graaf, M.T. de Beukelaar, J.W.K. de Bergsma, J. Kraan, J. Bent, M.J. van den Klimek, M. Norden, Y. van Kusuma, A. Smitt, P.S. Gratama, J-W.
2008-03-01
Beta-Blocking Agents and Electroconvulsive Therapy (Article)
Broek, W.W. van den Groenland, T.H.N. Kusuma, A. Birkenhäger, T.K. Pluijms, E.M. Bruijn, J.A. Mulder, P.G.H.
2007-04-01
Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study (Article)
Broek, W.W. van den Leentjens, A.F. Kusuma, A. Bruijn, J.A. Mulder, P.G.H.
1999-01-01